 2012 Highlights
• Signing of OEM agreement with Biotage AB for application
of MiD
®
in flash purification and unveiling of the
Biotage-Microsaic combined system 
• Commencement of regular production and shipments of
systems to customers and other potential OEM partners
• Development of the 4000 MiD
®
and of future products,
including working prototype of next-generation system, to
address new market areas 
• First shipments of the 4000 MiD
®
to Biotage and orders for
further systems 
• Appointment of Colin Jump as Chief Executive Officer 
• Microsaic’s 3500 MiD
®
wins R&D 100 award
Post-period update
• OEM agreement signed for the sale of the 4000 MiD
®
as a
stand-alone instrument
• 4000 MiD
®
launched at Pittcon international trade fair in
Philadelphia, USA 
• Biotage-Microsaic joint product, the ‘Isolera Dalton’
presented at the American Chemical Society National
Meeting
Financial summary
• Revenue up 126% to £0.61 million 
(2011: £0.27 million)
• Placing of 3,867,248 ordinary shares in June 2012
raising £1.45 million net
• Cash at 31 December 2012 £1.79 million 
(2011: £1.82 million)
• Loss for the year to 31 December 2012 £1.87 million
(2011: £1.90 million)
Microsaic Systems plc Annual Report and Financial Statements 2012 1
Highlights
